ACADIA Pharmaceuticals' stock is owned by a number of institutional and retail investors. Top institutional investors include Frontier Capital Management Co. LLC (0.60%), Peregrine Capital Management LLC (0.11%), Wealthstreet Investment Advisors LLC (0.09%), DNB Asset Management AS (0.03%), First Midwest Bank Trust Division (0.01%) and Kestra Advisory Services LLC (0.01%). Company insiders that own ACADIA Pharmaceuticals stock include Austin D Kim, Bros Advisors Lp Baker, Elena Ridloff, Eric Alejandro Miller, James M Daly, Laura Brege, Michael J Yang, Srdjan R Stankovic and Stephen Davis.
View institutional ownership trends for ACADIA Pharmaceuticals.